author-photo

Hans Bentzen

Aarhus University Hospital

31

Papers

756

Citations

Citation Trend

Filter By

Papers (21) Sort By

Journal Conference Others

Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort

2020 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (4)
Richter’s transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study

2020 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (6)
EARLY PROGRESSION OF MANTLE CELL LYMPHOMA DEPICTS A HIGH-RISK DISEASE WITH POOR RESPONSE TO SUBSEQUENT THERAPIES AND A DISMAL OUTCOME

2019 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor

2019 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (10)
Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study

2018 Blood Advances
Show All
- Source
- Cite
- Save
Citations (9)
Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

2017 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (37)
The Combination of Pixantrone, Etoposide, Bendamustine and, in CD20+ Tumors, Rituximab (PREBEN) Shows Promising Feasibility/Efficacy in Heavily Pre-Treated Aggressive Lymphomas of B- and T-Cell Phenotype - Results of the Pre-Trial Experience Leading to a Nordic Phase 1/2 Study (the PREBEN Trial)

2016 Blood
Show All
- Source
- Cite
- Save
Citations (9)
A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait

2015 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (20)
SOX11, CCND1, BCL1/Igh, and Igh-VDJ – a Plethora of Markers for Minimal Residual Disease in Mantle Cell Lymphoma: Which One to Choose?

2014 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Preliminary Clinical Experience on the Efficacy and Feasibility of a New Combination Regimen Consisting of Pixantrone, Etoposide, and Bendamustine with or without the Addition of Rituximab in Patients with Relapsed/Refractory Aggressive Non-Hodgkin Lymphomas

2014 Blood
Show All
- Source
- Cite
- Save
Citations (5)